Health Care & Life Sciences

Companies, including WellPoint, use buybacks to boost stock

March 11, 2014
Associated Press analysis
Companies have been spending big on buybacks since the 1990s. What's new is the way buybacks have exaggerated the health of many companies.
More

Purdue-based cancer imaging firm lands $15M in funding

March 11, 2014
J.K. Wall
OnTarget Laboratories LLC's technology was developed by Philip Low, a Purdue chemistry professor who also created the technology behind Endocyte Inc.
More

Timing looks right for Biomet IPO

March 10, 2014
J.K. Wall
After private equity firms paid $11.4 billion for Biomet Inc. just months before the onset of a prolonged downturn, they are now trying to take the company public when U.S. consumer sentiment is on the upswing.
More

Dow AgroSciences nears jackpot from genetic engineering

March 8, 2014
Dan Human
Dow AgroSciences LLC is spending millions of dollars and racking up hundreds of patents as its expands ever deeper in the burgeoning global market for genetically modified crops and pesticides.
More

UIndy looking for developer for health sciences centerRestricted Content

March 8, 2014
J.K. Wall
UIndy would be the main tenant in the 134,000-square-foot building, which is expected to cost as much as $30 million.
More

2014 Health Care Heroes: Timmy Global Health

March 6, 2014
Tom Harton
Community Achievement in Health Care Finalist
More

2014 Health Care Heroes: Patient Health Coaching, Franciscan Visiting Nurse Service

March 6, 2014
Tom Harton
Community Achievement in Health Care Finalist
More

2014 Health Care Heroes: Daughters of Charity

March 6, 2014
Tom Harton
Community Achievement in Health Care Winner
More

Two-year extension offered for canceled health plans

March 5, 2014
Associated Press
The extension was part of a major package of regulations that sets ground rules for 2015, the second year of government-subsidized health insurance markets under Obama's law — and the first year that larger employers will face a requirement to provide coverage.
More

Lilly diabetes drug rejected by FDA over manufacturing issue

March 5, 2014
Bloomberg News
The Lilly-Boehringer drug empagliflozin is projected to reach sales of $295 million for Lilly in 2019, but it won't be able to sell it until issues are resolved at a German plant.
More

Insurers’ Obamacare losses may reach $5.5 billion, U.S. says

March 5, 2014
Bloomberg News
Health insurers such as Indianapolis-based WellPoint Inc. and Louisville-based Humana Inc. stand to receive $5.5 billion next year to cover losses from Obamacare in a program the law’s opponents label a bailout.
More

House passes moratorium on nursing home construction

March 3, 2014
John Sittler, The Statehouse File
The bill passed 55-40 and now returns to the Indiana Senate, which has already passed the bill and can now approve changes made by the House or send the bill to a conference committee for further consideration.
More

Analysts: Endocyte likely to receive green light on first drug this month

March 3, 2014
J.K. Wall
The European Committee for Medicinal Products for Human Use is scheduled to meet March 17-20, and analysts expect the agency to vote during that meeting to approve vintafolide, Endocyte’s first drug, which treats ovarian cancer.
More

Indiana one of many states aiming to limit tanning

March 2, 2014
Associated Press
Lawmakers' efforts to crack down on the use of Indiana tanning beds this year are part of a national push to limit young people's exposure to risks that include skin cancer.
More

Kentucky's largest health system makes major jobs cut

March 1, 2014
Associated Press
Hospital company KentuckyOne Health, which employs more than 14,000 people in Kentucky and southern Indiana, says it has laid off about 500 people.
More

Tech firms dangle amenities to lure sought-after workersRestricted Content

March 1, 2014
Dan Human
Industry goliaths in Silicon Valley have thrown lavish perks at employees for years. As employment in Indianapolis tech firms has skyrocketed in recent years, a lot more companies are looking for workers, heating up competition.
More

Biosimilars bill passes House, heads to governor

February 25, 2014
Jacob Rund, The Statehouse File
Pharmacists would be able to substitute an interchangeable biosimilar drug for a prescribed name-brand product under a bill passed by the Indiana House of Representatives on Tuesday.
More

Lilly diabetes drug matches competitors' effectiveness

February 25, 2014
 IBJ Staff and Bloomberg News
The Indianapolis drugmaker said dulaglutide performed as well as Victoza, a best-selling drug for Type 2 diabetics made by Denmark-based Novo Nordisk. Analysts think dulaglutide could reach annual sales of $1.5 billion.
More

Indiana’s hospitals face Obamacare timing problem

February 24, 2014
J.K. Wall
The Obama administration's delays of Obamacare's employer mandate penalties mean it will be another year or two before hospitals see the additional revenue the law was supposed to bring them.
More

Lilly acquires animal health business, lowers forecast

February 24, 2014
 Associated Press and IBJ Staff
Eli Lilly and Co. is buying a privately held, poultry-vaccine maker based in Germany to strengthen its Elanco animal health subsidiary.
More

UIndy plans $50M in expansion projects

February 21, 2014
J.K. Wall
The bulk of the money, to be spent over five years, will go to a 134,000-square-foot health sciences center, which will provide training space for the university's nursing, physical therapy and other health care students.
More

WellPoint dismisses former interim-CEO Cannon

February 21, 2014
J.K. Wall
John Cannon, the man credited with righting the ship at WellPoint Inc., was terminated without cause this week, the company disclosed in a securities filing Friday morning.
More

Consumers shun cheapest Obamacare exchange plans

February 20, 2014
Bloomberg News
Most Americans are avoiding the lowest-priced health plans on the Obamacare insurance exchanges, taking advantage of government subsidies to seek more protection against high treatment costs.
More

Lilly drug shows promise as lung cancer treatment

February 19, 2014
J.K. Wall
Shares of Eli Lilly and Co. rose as much as 3.8 percent Wednesday morning after the Indianapolis-based drugmaker revealed that an experimental drug boosted overall survival among lung cancer patients in a large trial.
More

Hoosier lawmakers attack Obamacare's 30-hour rule

February 17, 2014
J.K. Wall
Lawmakers Young and Donnelly push restoration of 40-hour definition of full-time, but critics say their bills would gut Obamacare's employer mandate and lead to a decline in employer insurance coverage.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Really, taking someone managing the regulation of Alcohol and making himthe President of an IVY Tech regional campus. Does he have an education background?

  2. Jan, great rant. Now how about you review the report and offer rebuttal of the memo. This might be more conducive to civil discourse than a wild rant with no supporting facts. Perhaps some links to support your assertions would be helpful

  3. I've lived in Indianapolis my whole and been to the track 3 times. Once for a Brickyard, once last year on a practice day for Indy 500, and once when I was a high school student to pick up trash for community service. In the past 11 years, I would say while the IMS is a great venue, there are some upgrades that would show that it's changing with the times, just like the city is. First, take out the bleachers and put in individual seats. Kentucky Motor Speedway has individual seats and they look cool. Fix up the restrooms. Add wi-fi. Like others have suggested, look at bringing in concerts leading up to events. Don't just stick with the country music genre. Pop music would work well too I believe. This will attract more young celebrities to the Indy 500 like the kind that go to the Kentucky Derby. Work with Indy Go to increase the frequency of the bus route to the track during high end events. That way people have other options than worrying about where to park and paying for parking. Then after all of this, look at getting night lights. I think the aforementioned strategies are more necessary than night racing at this point in time.

  4. Talking about congestion ANYWHERE in Indianapolis is absolutely laughable. Sure you may have to wait in 5 minutes of traffic to travel down BR avenue during *peak* times. But that is absolutely nothing compared to actual big cities. Indy is way too suburban to have actual congestion problems. So please, never bring up "congestion" as an excuse to avoid development in Indianapolis. If anything, we could use a little more.

  5. Oh wait. Never mind.

ADVERTISEMENT